NP / PA
Hoar, Tanya
Hoar, Tanya was paid $211K by Medicaid between Nov 2018 and Dec 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 58% of everything it billed.
33Billing provider infoHOAR, TANYA
KENOSHA, WI 53143
KENOSHA, WI 53143
33aNPI1891933552assigned 02/03/2009
33bProvider typePediatric Nurse Practitioner
28Total paid$211K
24GClaims8,212
24DCodes billed40
24AFirst – last monthNov 2018 – Dec 2024
Compared with peers
Next to other Pediatric Nurse Practitioner providers in Wisconsin
Rank by total paid#2 of 16
Median peer was paid$10K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74 | $2K | |
| 2019 | 334 | $7K | |
| 2023 | 818 | $12K | |
| 2024incomplete | 6,986 | $190K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 58% | 2,036 | 1,767 | $122K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 264 | 221 | $14K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.2% | 217 | 196 | $13K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.9% | 147 | 137 | $10K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.9% | 135 | 122 | $8K |
| 99173 | 3.1% | 412 | 367 | $7K | |
| 92551 | 2.8% | 452 | 404 | $6K | |
| 99188 | 2.0% | 397 | 350 | $4K | |
| 3008F | 1.4% | 653 | 579 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 92 | 82 | $3K |
| 96127 | 1.2% | 486 | 442 | $2K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 74 | 68 | $2K |
28 more codes
| 90677 | <1% | 127 | $2K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 137 | $1K |
| 90686 | <1% | 117 | $1K | |
| 99000 | <1% | 308 | $1K | |
| 83655 | <1% | 107 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 16 | $1K |
| 80061 | Lipid panel | <1% | 80 | $956.83 |
| 90674 | <1% | 80 | $929.70 | |
| 90647 | <1% | 60 | $840.00 | |
| D1208 | Topical application of fluoride, excluding varnish | <1% | 65 | $824.96 |
| 90651 | <1% | 54 | $727.50 | |
| 36416 | <1% | 332 | $700.75 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 42 | $637.92 |
| 90619 | <1% | 37 | $491.70 | |
| 90716 | <1% | 35 | $435.00 | |
| 90707 | <1% | 32 | $405.00 | |
| 90620 | <1% | 13 | $378.12 | |
| 90633 | <1% | 32 | $330.00 | |
| 87807 | <1% | 25 | $308.01 | |
| 82947 | <1% | 81 | $265.76 | |
| 82948 | <1% | 71 | $191.26 | |
| 90680 | <1% | 12 | $180.00 | |
| 90723 | <1% | 12 | $180.00 | |
| 85018 | <1% | 43 | $111.53 | |
| 81025 | <1% | 14 | $105.16 | |
| 90461 | <1% | 269 | $59.31 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 576 | $51.61 |
| 36415 | Collection of venous blood by venipuncture | <1% | 70 | $21.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.